|Bid||59.23 x 1300|
|Ask||59.33 x 2900|
|Day's Range||57.70 - 59.60|
|52 Week Range||57.68 - 93.47|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||13.75|
|Earnings Date||Oct 25, 2022 - Oct 31, 2022|
|Forward Dividend & Yield||1.08 (1.84%)|
|Ex-Dividend Date||Aug 18, 2022|
|1y Target Est||77.58|
Subscribe to Yahoo Finance Plus to view Fair Value for CTSH
Law firm Freshfields Bruckhaus Deringer selects Cognizant (CTSH) to manage its IT infrastructure, applications and service desk.
Let's talk about the popular Cognizant Technology Solutions Corporation ( NASDAQ:CTSH ). The company's shares saw...
Cognizant (NASDAQ: CTSH) announced that its Shared Investigator Platform (SIP), a life sciences Software as a Service (SaaS) solution that streamlines clinical trials to improve the speed of pharmaceutical drug discovery, has surpassed 250,000 users across 100 countries worldwide. This digital platform facilitates research and collaboration around the globe by allowing clinical study documents and safety notifications to be easily and securely exchanged across site and sponsor teams.